Bill

HR 3042

MMEDS Act of 2025

119th Congress Introduced by Vern Buchanan and 9 co-sponsors

The MMEDS Act of 2025 boosts U.S. medical manufacturing, creating jobs and promoting sustainability, ensuring competitive access to domestic medical supplies.

Introduced in House

WeVote Research Nonpartisan

Bill Summary · HR 3042

Summary of HR 3042 - MMEDS Act of 2025

Overview

The Medical Manufacturing, Economic Development, and Sustainability Act of 2025, commonly referred to as the MMEDS Act of 2025, was introduced in the House of Representatives on April 28, 2025. The bill aims to enhance the medical manufacturing sector while promoting economic development and sustainability practices within the industry.

Purpose and Intent

The primary purpose of the MMEDS Act is to:
- Strengthen the domestic medical manufacturing industry.
- Foster economic growth through job creation and investment in sustainable practices.
- Ensure that the United States remains competitive in the global medical manufacturing market.

Key Provisions

While the full text of the bill has not been provided, the following key areas are expected to be addressed based on the title and intent:
- Incentives for Medical Manufacturing: The bill may propose tax incentives or grants to encourage companies to invest in medical manufacturing facilities and technologies.
- Sustainability Initiatives: It is anticipated that the legislation will include provisions aimed at promoting environmentally friendly practices in the production of medical devices and pharmaceuticals.
- Economic Development Programs: The bill could establish programs designed to support workforce development and training in the medical manufacturing sector.

Affected Parties

The MMEDS Act is likely to impact:
- Medical Manufacturers: Companies involved in the production of medical devices, pharmaceuticals, and related technologies will be directly affected by the incentives and regulations proposed in the bill.
- Healthcare Providers: Hospitals and clinics may benefit from improved access to domestically produced medical supplies and devices.
- Workers: The bill aims to create jobs in the manufacturing sector, potentially benefiting workers in related fields.

Legislative Process

Introduced: April 28, 2025
Referred to Committees: The bill has been referred to the Committee on Ways and Means and the Committee on Energy and Commerce for further consideration. The Speaker of the House will determine the timeline for these committees to review the bill.

Conclusion

The MMEDS Act of 2025 represents a significant legislative effort to bolster the medical manufacturing industry in the United States while promoting sustainable practices and economic growth. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and potential impacts.

Compiled from official sources — confirm details with the bill’s official record.